Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages

References

• American Society of Health-System Pharmacists. 1997. ASHP Therapeutic position statement on the safe use of niacin in the management of dyslipidemias. Am J Health Syst Pharm, 54:2815–2819.
   PubMed Web of Science ®Google Scholar
• Bechgaard H, Jespersen S. GI absorption of niacin in humans. J Pharm Sci 1977; 66: 871–872
   PubMed Web of Science ®Google Scholar
• Benyo Z, Gille A, Kero J, Csiky M, Suchankova MC, Nusing RM, Moers A, Pfeffer K, Offermanns S. GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J Clin Invest 2005; 115: 3634–3640
   PubMed Web of Science ®Google Scholar
• Benyo Z, Gille A, Bennett CL, Clausen BE, Offermanns S. Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. Mol Pharmacol 2006; 70: 1844–1849
   PubMed Web of Science ®Google Scholar
• Carlson LA. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review. J Intern Med 2005; 258: 94–114
   PubMed Web of Science ®Google Scholar
• Cayen MN. Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Pharmacol Ther 1985; 29: 157–204
   PubMed Web of Science ®Google Scholar
• Cefali EA, Simmons PD, Stanek EJ, Shamp TR. Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation. Int J Clin Pharmacol Ther 2006; 44: 633–640
   PubMed Web of Science ®Google Scholar
• Cheng K, Wu TJ, Wu KK, Sturino C, Metters K, Gottesdiener K, Wright SD, Wang Z, O'Neill G, Lai E, Waters MG. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans. Proc Natl Acad Sci USA 2006; 103: 6682–6687
   PubMed Web of Science ®Google Scholar
• Gille A, Bodor ET, Ahmed K, Offermanns S. Nicotinic acid: Pharmacological effects and mechanisms of action. Annu Rev Pharmacol Toxicol 2008; 48: 79–106
   PubMed Web of Science ®Google Scholar
• Guyton JR, Bays HE. Safety considerations with niacin therapy. Am J Cardiol 2007; 99: 22C–31C
   PubMed Web of Science ®Google Scholar
• Kamanna VS, Vo A, Kashyap ML. Nicotinic acid: Recent developments. Curr Opin Cardiol 2008; 23: 393–398
   PubMed Web of Science ®Google Scholar
• Lorenzen A, Stannek C, Lang H, Andrianov V, Kalvinsh I, Schwabe U. Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol 2001; 59: 349–357
   PubMed Web of Science ®Google Scholar
• Maciejewski-Lenoir D, Richman JG, Hakak Y, Gaidarov I, Behan DP, Connolly DT. Langerhans cells release prostaglandin D2 in response to nicotinic acid. J Invest Dermatol 2006; 126: 2637–2646
   PubMed Web of Science ®Google Scholar
• McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 2004; 164: 697–705
   PubMed Web of Science ®Google Scholar
• Menon RM, Adams MH, Gonzalez MA, Tolbert DS, Leu JH, Cefali EA. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation. Int J Clin Pharmacol Ther 2007; 45: 448–454
   Google Scholar
• Meyers CD, Liu P, Kamanna VS, Kashyap ML. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis 2007; 192: 253–258
   PubMed Web of Science ®Google Scholar
• Mills E, Prousky J, Raskin G, Gagnier J, Rachlis B, Montori VM, Juurlink D. The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]. BMC Clin Pharmacol 2003; 3: 4
   PubMedGoogle Scholar
• Mularski RA, Grazer RE, Santoni L, Strother JS, Bizovi KE. Treatment advice on the internet leads to a life-threatening adverse reaction: Hypotension associated with niacin overdose. Clin Toxicol (Philadelphia) 2006; 44: 81–84
   Web of Science ®Google Scholar
• Neuvonen PJ, Roivas L, Laine K, Sundholm O. The bioavailability of sustained release nicotinic acid formulations. Br J Clin Pharmacol 1991; 32: 473–476
   Google Scholar
• Norquist JM, Watson DJ, Yu Q, Paolini JF, McQuarrie K, Santanello NC. Validation of a questionnaire to assess niacin-induced cutaneous flushing. Curr Med Res Opin 2007; 23: 1549–1560
   PubMed Web of Science ®Google Scholar
• Pasternak RC, Kolman BS. Unstable myocardial ischemia after the initiation of niacin therapy. Am J Cardiol 1991; 67: 904–906
   Google Scholar
• Pieper JA. Understanding niacin formulations. Am J Manage Care 2002; 8: 308–314
   PubMed Web of Science ®Google Scholar
• Pike NB. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid. J Clin Invest 2005; 115: 3400–3403
   PubMed Web of Science ®Google Scholar
• Rachmilewitz M, Glueck HI. Treatment of pellagra with nicotinic acid. BMJ 1938; 2: 346–348
   Google Scholar
• Sebrell WH, Butler RE. A reaction to the oral administration of nicotinic acid. JAMA 1938; 111: 2286–2287
   Google Scholar
• Soudijn W, Ijzerman AP. Nicotinic acid receptor subtypes and their ligands. Med Res Rev 2007; 27: 417–433
   PubMedGoogle Scholar
• Spies TD, Bean WB, Stone RE. The treatment of subclinical and classical pellagra. Use of nicotinic acid, nicotinic acid amide and sodium nicotinate, with special reference to the vasodilator action on mental symptoms. JAMA 1938a; 111: 584–592
   Google Scholar
• Spies TD, Cooper C, Blankenhorn MA. The use of nicotinic acid in the treatment of pellagra. JAMA 1938b; 110: 622–627
   Google Scholar
• Stephenson LA, Kolka MA. Increased skin blood flow and enhanced sensible heat loss in humans after nicotinic acid ingestion. J Therm Biol 1994; 20: 409–423
   Google Scholar
• Svedmyr N, Harthon L, Lundholm L. The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man. Clin Pharmacol Ther 1969; 10: 559–570
   PubMed Web of Science ®Google Scholar
• Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med 2003; 9: 352–355
   PubMed Web of Science ®Google Scholar
• van den Berg H. Bioavailability of niacin. Eur J Clin Nutr 1997; 51: 64–65
   PubMedGoogle Scholar